University of Montana

ScholarWorks at University of Montana
Graduate Student Theses, Dissertations, &
Professional Papers

Graduate School

1991

Relationship of outer membrane proteins II of Neisseria
gonorroheae [sic] to colony opacity and serum killing
Jing Chen
The University of Montana

Follow this and additional works at: https://scholarworks.umt.edu/etd

Let us know how access to this document benefits you.
Recommended Citation
Chen, Jing, "Relationship of outer membrane proteins II of Neisseria gonorroheae [sic] to colony opacity
and serum killing" (1991). Graduate Student Theses, Dissertations, & Professional Papers. 3395.
https://scholarworks.umt.edu/etd/3395

This Thesis is brought to you for free and open access by the Graduate School at ScholarWorks at University of
Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an
authorized administrator of ScholarWorks at University of Montana. For more information, please contact
scholarworks@mso.umt.edu.

Maureen and Mike
MANSFIELD LIBRARY
Copying allowed as provided under provisions
of the Fair Use Section of the U.S.
COPYRIGHT LAW, 1976.
Any copying for commercial purposes
or financial gain may be undertaken only
with the author's written consent.
University of

Montana

The Relationship of Outer Membrane Proteins II
of Neisseria aonorroheae to Colony
Opacity and Serum Killing

BY JING CHEN
B.S., Sichuan Medical College

1983

Sichan, P.R.China
Presented in Partial Fulfillment
of the requirements for
the degree of Master
of Science
1991

Approved by

Chair, Board of Examiners

Dean. Graduate ^School

ITMI Number: EP34713

All rights reserved
INFORMATION TO ALL USERS
The quality of this reproduction is dependent on the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.

UMT
UMI EP34713
Copyright 2012 by ProQuest LLC.
All rights reserved. This edition of the work is protected against
unauthorized copying under Title 17, United States Code.

*
ProQuest LLC.
789 East Eisenhower Parkway
P.O. Box 1346
Ann Arbor, Ml 48106-1346

CHEN, JING., M.S. January,

1991

Microbiology

The relationship of outer membrane protein II of Neisseria
cronorroheae to colony opacity and serum killing
(86pp.)
Director: Dr. Ralph C. Judd
Outer membrane protein II (PII) variants in seven
gonococcal strains were isolated with the indication of
colony opacity and sodium dodecyl sulfate-polyacrylamide gel
electrophoresis. High frequency switching in PII expression
of organisms was indicated by variation in colony opacity.
These extensive changes of PII expression possibly help
organisms evade host immune response and increase the
ability of bacteria to adjust to different internal
environments. Gonococci forming opaque colonies posses a
group of PIIs that are lacking in organisms which form the
transparent colonies. In experimental strain FA899, the
opaque phenotype colonies were observed despite the absence
of PIIs in those colonies, which implies the involvement of
other surface structures the colony opacity.
The serum sensitivity of opacity variants was examined
with microassay. The opaque variants tend to be more
resistant to normal human serum (NHS) than isogeneic
transparent colonies. These results suggest that expression
of PIIs enhance bacterial survival in the host.
Unlike other serum assays, serum killing in this
microassay is likely mediated by a group of heat stable lowmolecular-weight cationic proteins other than complement.
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CHAPTER I

INTRODUCTION

Neisseria gonorrhoea (GC), the pathogenic agent of
gonorrhea, is one of the most common sexually transmitted
diseases in humans (7). It causes diseases ranging from
uncomplicated genital infections to complicated infections
including pelvic inflammatory disease and disseminated
gonococcal infection (DGI) (7, 50).

Human mucosae, such as

the urethra, rectum, pharynx conjunctiva and endocervix (7)
are most commonly infected.
even the unborn.

GC infects men, women, infants,

In recent years, antibiotic-resistant

strains of GC have appeared, causing an increasing in cases
not responsive to treatments of antibiotics (15).

GC

infects individuals worldwide at any time of the year, not
just in seasonal epidemics or in localized areas.

Despite

considerable efforts to control its infection, gonococcal
disease still remains a common public health problem.
Approximately 375 cases per 100,000 population were reported
in the United States in 1987 (11).
Structural variation of surface components is one
effective way used by many pathogens to evade the host
immune response.
responses.

GC uses this method to evade host immune

The antigenic determinants on the membrane

surface of GC, such as outer membrane proteins (OMPs) and
lipopolysaccharide (LPS), appear to play a major role in
pathogenesis.

Those surface factors can change rapidly,

making it possible for this gram-negative diplococcus to
evade the host immune defense, conferring significant
advantages in bacteria survival, and allowing GC to adapt to
changes in the host environment. Antigenic variation (12,
41, 77, 78) and natural transformation (73) are thought to
be responsible for those extensive variations.

The

variability of outer membrane (OM) structures has
contributed to our general failure to develop a vaccine and
probably account for multiple and recurrent gonococcal
infections (95).
Pili are hairlike structures present on surface of GC.
They consist of identical multiple pilin subunits.

Pili

range in molecular mass from about 19,000 dalton 19K to 25K
(64, 71).

Pili are one of the predominant variable factors

of the OM and play an extremely important role in the GC
pathogenesis (83).
Specific gonococcal colony forms were correlated with
GC virulence by Kellogg, et al (42, 43, 83).
types are observed Tl, T2, T3, T4.
morphologically different (8).

Four colony

Each colony type was

Type 1 and type 2 (virulent)

produced typical acute venereal infection whereas type 3 and
type 4 (avirulent) caused only mild, transient symptoms
without establishment of infection (42, 43).
2

Pili have been

found only on the cells of type 1 and 2 and are absent from
type 3 and 4 (3, 82).

Data by J. Swanson and others (9, 24,

60, 83) suggested that piliated small colonies of GC are the
invasive form of the species.

This suggests a correlation

between the virulence of GC and the presence of pili.
Chromosomal rearrangements, such as deletions of pilus genes
and intragenic recombination cause phase and antigenic
variation.

This enhances bacterial survival and virulence

(18, 22, 55, 74).

It has been shown that pili are involved

in the first of a two-stage attachment process of GC
infection.

They help overcome the electrostatic barrier

which exists between the negative charged surfaces of
gonococcus and the host cell (24).

Purified gonococcal pili

attach to the cervical-vaginal and buccal epithelial cells
(normal host cells) much better than they attach to the
erythrocytes, leukocytes or fibroblast (59).

This finding

suggests that a specific relationship exists between GC and
their host cells.

Receptors on the host cells can

specifically bind to the receptor-binding domain of the
pilus molecule has been found.

This site consists of 80

amino acid residues from 31 to 111 of pilus molecule (71).
Antibodies against pili specifically block this binding,
dramatically reducing the attachment to the host cells.
This characteristic has made pili a potential candidate for
a vaccine.

However, indicative efforts to develop a pilus

vaccines have not been successful, suggesting that the
3

extensive changes of pilus molecules caused by the phase and
antigenic variation (76) may make pili unsuitable for a
vaccine.
Outer membrane protein I (PI), which is present in all
gonococci examined, is the major OMP of GC

with a molecular

mass varying from 34K to 38K (1, 36). It varies in subunit
molecular mass among strains but is identical for all
intrastrain variants (1) and accounts for approximately 60%
of the protein in the OM (31).

Two major groups of Pis, PIA

(34-36KDa) and PIB (36-38KDa), have been recognized in the
OM of GC and can be further subdivided by using monoclonal
antibodies (MAbs) (44).
differently in the OM.

PIA and PIB appear to be orientated
The PIAs have their N-terminal 15-20

amino acids exposed on the surface (1), while PIBs have both
termini buried in the membrane, with a central region
exposed on the surface (1, 38, 40).

These two subclasses

are structurally and electrophoretically distinct.

Certain

biological characteristics have been correlated with the PI
types that the organisms bear.

Pis affect the inhibition of

bacterial growth by proteolytic enzymes, and influence
sensitivity to serum killing (28). The strains isolated
from the blood stream of patients with DGI are usually
resistant to the bactericidal action of normal human serum
(NHS) and tend to belong to the PIA group.

Strains isolated

from uncomplicated genitourinary disease tend to belong to
group PIB and are often serum sensitive (39, 70).
4

Because

of the distinctive exposure of PI subclass molecules in the
OM, PIAs are resistant to in situ cleavage by achymotrypsin, trypsin and proteinase K, while PIBs are much
more susceptible to those enzymes.

The molecular mass of PI

has been correlated with serum sensitivity, with strains
bearing PI of the higher molecular mass more sensitive to
NHS killing (9, 29).

Pis also serve as porins which form

hydrophilic channels across OM and are the major
determinants for serotypic specificity in the membrane (31).
Although the PIA in GC strains WS3 and WS5 are identical, a
slight alteration of exposure of PIAs present in these two
strains was correlated with altered LPS and /or H.8 antigen
structure found in those two strains.

Many more alterations

of exposure of PIBs were found in strains WS2 and WS4 which
also correlated with the variations in LPS and/or H.8
antigen structure (41).

It is possible that PI with LPS and

/or H.8 antigen form a complex on the OM.

Since PI appears

to be invariant within a strain, this implies the organism
may have developed a mechanism to protect this molecule from
the immunological attack of the host by changing the other
OM components (41).
Outer membrane Proteins II (PII), a group of
heat-modifiable proteins on the surface of gonococci, may be
important virulence associated OMP.

They range in apparent

molecular mass from 24KDa to 30KDa and are highly exposed on
the surface of the bacteria (6, 25, 26, 65, 86).
5

Since they

correlate with difference in colony opacity, they are also
called opacity-associated proteins (25, 31, 45, 88, 90, 96).
Although PII molecules show a high degree of sequence
conservation in their primary structure, they are function
ally, serologically, and structurally distinguishable (89).
The difference has been seen in primary structure, antigenic
determinants, and migration in SDS-PAGE gels (14, 27, 37,
86, 88).

A single organism can express from zero to four

PII species with different combinations, with a single
strain (MSll) able to produce as many as 11 electrophoretically distinct PII variants (2, 4, 14, 72, 88).
Protein lis are not structurally related to any of the
other OMPs (37).

The members of the PII family share about

60% homology when compared by peptide mapping of
a-chymotrypsin digests of purified proteins.

The other 40%

of the peptide are unique to each PII and represent the
portion of the molecule which is exposed on the surface of
bacteria (27, 37, 86).

Antisera from purified PIIs of three

strains react with PIIs of all heterologous strains, but the
strongest reactions are with homologous PIIs (54, 72).
However MAbs are very specific for each PII, showing little
cross reactivity with other PIIs (4).

Confirming PII

peptide mapping, the DNA sequence of two cloned PII genes
shows that they are very similar in large regions (80%
homology) with difference only

in two short hypervariable

(HV) regions and a semivariable region which encodes the
6

N-terminal amino acids (77).

Those two short hypervariable

regions are responsible for most of the differences of PIIs
(12).

The restriction fragments containing only the HV

regions cloned into an expression vector demonstrated that
the epitopes recognized by specific PIIs monoclonal
antibodies were completely encoded by either HV, or HV2
(13).
PIIs are subject to extensive phase and antigenic
variation (76, 77, 78).

The genes are switched on and off

nonrandomly at very high frequency.

The average rate of

change is about 2xl0~3 per cell per generation (48).

This

is too high to be explained by random mutation and
reversion.

This rate is not affected by the

change in

growth temperature, pH, amount of oxygen present, or state
of piliation (48), but some substances such as pyruvate may
induce the phenotypic change of GC (56, 57).
The expression of PIIs is controlled by a group of
genes spread over throughout the gonococcal genome (77). At
least nine expression loci (opa E) are involved in
production of a large number of serologically distinct
phenotypic variants.

No correlation was found between the

number of proteins produced and the number of opa loci; each
locus may not be active in the production of a protein (93).
The DNA sequence rearrangement that controls Salmonella
phase variation may also contribute the rapid reverse
phenotype changes in gonococci (12, 96).
7

The recombination

among PII genes generates new coding sequences and
contributes to the increase of structural variability in the
PII family (12).

Also, the genetic transformation of PII

genes from a donor into a recipient was detected by MAbs
(73).

The DNA sequence rearrangement, PII genes

recombination, and genetic transformations are thought to be
responsible for the antigenic variation.

Regulation of PII

phase variation commonly occurs at the translation level
(73, 77).

A striking finding has been made when analyzing

the opa-genes.

All the opa-related genes appear to have a

common 5'-coding sequence which includes a repetitive
sequence, termed the coding repeat (CR).
pentameric CTCTT units.

CR composed of

The number of the repeating units

that code for the hydrophobic part of a leader or signal
peptide is variable while all expression loci in a single
cell are constitutively transcribed.

However, the

production of functional opacity proteins can only occur if
the translational start codon ATG is in frame. The reading
frame is controlled by the repeat sequence at translational
level.

Such repeat sequences can be spontaneously added or

lost maneuvering the PII structural genes into or out of
frame with ATG initiation codon so that either full-sized
PII protein or a truncated protein is synthesized (77, 78).
CR variation is thought to be the basic mechanism involved
in phase and antigenic variation of PIIs expression (53,
58).

Insertion and deletion of CTCTT repeats probably
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involves slipped-strand mispairing of the DNA which occur
during DNA replication or non-replication duplex.

Changes

could also result from unequal crossing-over among the
signal peptide coding regions of different PII genes in the
chromosome (53).

Phenotypic changes of GC associated with

variable PII expression occur not only in vitro but also in
vivo during the course of gonococcal infection (60, 72, 89).
Cultures from male urethrae tend to contain more opaque or
(Pll-bearing) colonies than those from female cervices (30).
It was also found that cultures isolated at different
anatomical locations have different predominant PII
phenotypes.

Even the cultures taken from the same location

at different time intervals show different PII phenotypes.
The phenotype of cultures taken from cervices depends on the
stage of the menstrual cycle and whether or not the
contraceptives have been used (30, 85, 90).
The function of PIIs has not been definitively
determined. But this group of proteins has been
characterized by:
1. Heat-modifiablity:

It is a very specific characteristic

of PIIs and has been used to recognize PII bands on an SDSPAGE gel.

After heat-modification (solubilized sample at

100°C), PIIs migrate more slowly in SDS-PAGE gel.

The PII

bands, appeared on the SDS-PAGE gel with the cells
solubilized at 37°C disappeared when solubilized the cells
at 100°C, and the new bands with larger molecular mass
9

appear instead (88).
2. Relationship to colony opacity:

In general the colonies

are transparent when the organism lacks expression of PIIs.
Different PII types have been correlated with distinctive
degrees of colony opacities (88), however some PIIs do not
show a discernible increase in colony opacity when present
alone or in combination with other opacity-associated PIIs
(30, 84, 85).

Colony opacity is also thought to be a very

reliable criteria used to select the different PII variants.
3. Virulence association:

Mucosal isolates tend to have

PIIs, while isolates from the blood always lack PIIs (46).
The organisms expressing PIIs have been shown to be less
virulent in the chicken embryo-model than those lacking PIIs

(66).
4. Sensitivity to protease:

PIIs are more sensitive to

hydrolysis by trypsin than the major outer membrane protein
(PI) of GC (85).

It is of interest that the other outer

membrane proteins in organisms containing PIIs are more
sensitive to hydrolysis by trypsin than in those organisms
which do not contain PIIs (5, 30, 84, 85).
5. Interaction with neutrophils:

Most but not all PIIs can

stimulate neutrophil respiratory burst and phagocytic
killing. This ability of protein II bearing gonococci is
mediated by lectin-like components, including a number of
simple monosaccharides and sugars (62).

Pll-lacking GC

adhered poorly to neutrophils and the GC were not killed at
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the same rate as Pll-bearing bacteria (16).
6. Ability to adhere to diverse types of eucaryotic cells:
PIIs appear to be important in attachment to the diverse
eucaryotic cells (16, 45, 65).

Colonies possessing PIIs

tend to clump together while colonies not expressing PIIs
are less adherent to each other (84). MAbs against PII can
specifically inhibit the attachment of GC to Hela cells (81)
helping to prevent infection.

The interaction of PII with

host cell surface components has been studied, showing that
the predominant binding interactions were with proteins
rather than carbohydrates. The chemical nature of
interaction is very complex, involving more than purely
ionic or hydrophobic forces (3).
7. Change serum resistance: increased sensitivity to killing
by normal human serum (NHS) has been shown to correlate with
PII expression (29), but P. R. Lambeden reported the
opposite results in his experiments in 1979 (46).
It is likely that expression of distinct PIIs in
variants of GC helps them to evade host responses and to
survive in different micro-environments.
Outer membrane PHI, a surface exposed protein which is
present in all GC strains examined (87).

It appears to be

30KDa to 31KDa daltons and to be biochemically and
immunologically identical in all strains studied (36, 63).
In marked contrast to the PI and PIIs, no phase or antigenic
variation has been noted in PHI. So it is likely that PHI
11

is a cross reactive antigen among all GC, but the antisera
raised against whole JS1 could not immunoprecipitate PHI of
JS3.

This suggests that PHI is either non-immunogenic or

non-antigenic in intact organisms (36). PIII is only
present in outer membranes of fresh isolates and is labelled
with

125I

in outer membrane preparations (26).

The functions

of PHI are not known, however it is possible that this
protein serves as a target for blocking antibodies found in
NHS which block the bactericidal activity of NHS (35, 63).
Protein III is closely associated with PI and may,
therefore, contribute to the function of the OM pore formed
by PI (63).
H.8 antigen, another antigenic determinant on the outer
membrane of GC, is a lipoprotein with an unusual amino acid
sequence (20, 79).

It appears to be invariable in

intrastrain variants (80) and it stains poorly with the
common stains used for visualizing the proteins on SDS-PAGE
(Silver and

Coomassie Brilliant Blue) (10).

These staining

characteristics can be explained by its unusual amino acid
sequence, rich in alanine and proline, and the lack of
aromatic and sulfur-containing amino acids.

It is protease-

sensitive, heat-modifiable but is not modified by 2-ME (10).
The functions of this antigen are not clear.

It is only

detected in pathogenic gonococci and meningococci, but it is
not found in nonpathogenic Neisseria species.

This suggests

that H.8 antigen may be an important virulence factor of
12

gonococcus (10).
Lipopolysaccharide (LPS) is an antigenic determinant
found on the surface of GC and another variable factor on
the OM (19, 51, 75).

It appears to have a critical role in

determining the sensitivity of gonococcus to NHS (21, 75).
LPS interacts with membrane proteins and appears to
influence the exposure of PI on the surface of bacteria
(41).

LPS varies in size, structure, and antigenic

expression both among strains and within strains.

The

chemical composition and structure of GC LPS are largely
unknown.

Three antigenic determinants have been indicated

on the LPS molecules of GC: the common, variable and
serotype antigens (51).

The common antigen is present on

all LPS molecules of GC, whereas the variable antigen may or
may not be present.

At least

found on the LPS of GC.

six serotype antigens are

Unlike the LPS in other

gram-negative bacteria, the LPS of GC has very short or no
"O"-antigenic side chains (51).
Resistance to killing by NHS is a common phenomenon of
gram-negative microorganisms (91, 94) and an important
determinant of virulence in at least some infections due to
gram-negative bacteria; although much of the literature does
tend to show a relationship between sensitivities to serum
and the ability to cause infection.

The precise role and

relative importance of serum resistance at any stage of the
infection process is not clear at present.
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The majority of

GC strains isolated from patients with DGI are resistant to
serum-killing, whereas strains isolated from mucosal sides
are often sensitive to serum-killing (67).

Two distinct

forms of serum resistance have been observed (49).

The

first (stable) form of serum resistance persists during
prolonged repeat passages on agar and was lost only when
colony morphology changed.

The second (acquired) form of

serum resistance was discovered by selecting survivors in
serum containing media.

The acquired form of resistance was

rapidly lost during repeated passage on agar without any
changes in colony type.

The factor in the serum which

appeared to be stable to heating at 56°c was thought to be
responsible for the acquired form of resistance.

After

dialysis, resistance-enhancing activity was found in the low
molecular weight (12KDa to 14KDa) diffusate of serum.

This

resistance was greatly reduced by prolonged or low
temperature (8°C) incubation and enhanced by lowered PH
(94).
Bactericidal activity of NHS against gram-negative
microorganisms involves both antibody and complement, but
surprisingly little is known about the target antigens and
how the serum resistant strains evade the host defense
system (93). Antigonococcal AB in NHS

result, ixonv tYve

presence of commensal gram-negative bacteria or with
nonpathogenic Neisseria found in the respiratory tract.
This is supported by the observation that AB can be removed
14

by absorption with some gram-negative organisms (19).

The

result of AB binding to GC is the activation of complement
cascade. The resultant C5b-9 membrane attack complex (MAC)
causes the lysis of cells.
may also be involved.
pathway activation.

Alternative activation pathways

C4 is essential for alternative

However, the C4-deficient serum can

still activate complement, but at a slower rate (68).

No

difference exists in the amount of complement activated nor

I

in the MAC formation between the serum sensitive and
resistant strains (23, 32, 33).

However, the MAC fails to

insert properly into the membrane of serum-resistent strains
(17).

Joiner, et al (34), demonstrated that C5b-9 forms

high molecular weight complexes with outer membrane
constituents of the serum-resistant strains, but not with
serum-sensitive strains.

These high molecular weight

complexes may be responsible for the failure of the MAC to
insert into the OM properly in resistant strains.

Recent

research has shown that blocking ABs for some surface
components, especially PHI (63), which protect those
surface components from attack by the specific bactericidal
antibodies, may also contribute to the resistance of killing
by NHS.
LPS is the main target antigen for ABs in the NHS (19,
68, 69, 75).

For many years, researchers have tried to

establish the relationship between LPS and sensitivity to
killing by NHS. Several characteristics of LPS , such as the
15

molecular weight variation and the difference in sugar
composition, have been associated with serum-sensitivity,
but no consistent correlation with a single variant has been
found (68).

The 3.6KDa LPS component is commonly expressed

by serum-resistant strains in varying amounts.

The antibody

specific for this 3.6KDa LPS is not found in the NHS, but
when this antibody is added to NHS, it will initiate the
lysis of bacteria mediated by human complements (9).

This

might mean 3.6 KDa LPS is although immunogenic, but it is
not antigenic.
PIAs are associated with serum-resistance (39).

The

higher the molecular masses of the PIAs are, the more
sensitive the bacteria are to the killing by NHS.

It is

interesting that among bacteria having the same PI,
transparent colonies (organisms bearing no PII) appear to be
more resistant to serum killing than opaque bacteria.
Bacteria which survive in the presence of NHS tend to shut
off PII expression and revert to transparent colonies (29).
A genetic locus (sac-1) which has an effect on the level of
serum resistance of GC was identified by Cannon, et al (9).
This locus is closely linked to, but not identical with, a
second locus (nmp-2) that affects PI.
Many surface components of GC are involved in the serum
sensitivity.

The contributions of each of these components

to the total serum sensitivity is still unclear.

16

Overall Objective:
As mentioned above, the PIIs are important OM proteins
of GC They are associated with variation in virulence
properties such as susceptibility to the bactericidal
activity of NHS, attachment to diverse eucaryotic cells,
susceptibility to phagocytosis and protease.

Therefore,

they may play an important role in GC infections.
This study proposes to study seven well characterized
strains of GC (WS1, WS2, WS3, WS4, WS5, FA102, FA899) to
elucidate the pattern of their PII expression.

I will try

to determine which PIIs are expressed and how many PIIs are
produced in each strain.

Since some strains (FA102 and

FA899) are parent strains of others, it will be of interest
to find out the relationship of PII expression in the
parental and their derivative strains.

I will then attempt

to determine the relationship of PII expression to
resistance and sensitivity to killing by NHS in WS1, WS2,
WS3, WS4, WS5, FA102, and FA899.

Results should help us to

understand the role that PIIs play in serum resistance and
propagation of GC infection in general.

Research Goal
1. Determination of

PII types expressed in a set of seven

transformant strains of N. gonorrhoea.
2. Comparison of

the expression of PII of a parent stain

with that of its derivative strains of N. gonorrhoea.
17

3. Correlation of PII expression with PI and LPS.
4. Examination of the possible relationship between PII
expression and sensitivity to bactericidal action of
NHS in strains WS1, WS2, WS3, WS4, WS5, FA102 and FA899.

18

CHAPTER II

MATERIALS AND METHODS

Bacteria:
well

Seven strains of N. gonorrhoea. which have been

characterized in our lab, were used in the

experiments.

Table 1 details the origins and serum killing

phenotypes of these strains (Results from Robin K. Pettit's
experiments in our lab).

The reason that I chose those

particular seven strains, is that they have been w^ll
characterized in our lab and they are all genetically inter
related (transformants).

FA102 and FA899 are general parent

strains of five other strains WS1, WS2, WS3, WS4, WS5.

Four

out of seven (FA102, WS1, WS3, WS5) have PIA and the other
three (FA899, WS2, WS4) have PIB.

The pictures of their PII

expression will give us clear information about genetic
events that happened when different PIIs were expressed.
These characterized strains could be used to establish the
role of PII molecules in a variety of cellular functions.
PI is an important factor that affects the sensitivity
to serum killing, but it is not the only factor.

The other

surface components such as LPS and PIIs also change the
serum sensitivity.

Table II (on page 21) shows protein I

type, migration of LPS, and H.8 antigen of these seven
19

strains (41).
It is interesting to compare the variants which have
the same PII expression with different PI backgrounds, and
also the variants having the same PI background, but with
different
PIIs expressed.
The strains were grown on the modified clear typing
agar as previously described (84) at 37°C in 5% C02
atmosphere.

Single colonies were selected and passed each

day to ensure that pure cultures of each colony type were
used.

Colonies were chosen on the basis of color and

opacity characterized by the criteria of J. Swanson (88) and
verified by sodium dodecyl-sulfate polyacrylamide gel
electrophoresis (SDS-PAGE).
Electrophoresis:

Colonies with various opacities which

reflect Pll-types, were harvested from solid medium into
1.5ml of complete Dulbecco phosphate buffered saline pH 7.4
(dPBS) and the absorbance was read with Coleman Junior II
spectrophotometer.

The suspensions were adjusted to optical

density (OD) 0.68 at 600nm, and centrifuged at 10,000 R.P.M
for 1 min. The pellets were solubilized in SDS solubilizing
solution containing 4% of
2-mercaptoethanol at 37°C and 100°C as previously described
(12).

The whole cell lysates were separated by

electrophoresis on an SDS-PAGE (12.5% acrylamide) for about
2 h at 10W constant power.

The gels were then fixed in 7%
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acetic acid -25% isopropyl alcohol (IPOH) overnight and
stained with 0.2% Coomassie Brilliant Blue (CBB). The
molecular mass of each PI and PII was determined on the gel
by comparison with molecular weight markers (Bio-Rad low MW
marker standards kit).

In addition, silver staining was

performed on 15% acrylamide with double cross linkage (1:16)
SDS gel, as described Tsai and Frash (92) to show the LPS
patterns ofdifferent variants in each strain.
Microscopy:

A stereo microscope (Stereo Zoom 7 Bausch &

Lomb, Rockester NY) equipped with a substage reflector
having both a diffusing surface and a plane polished mirror
was used for discerning the color and opacity characteris
tics of gonococcal colonies.
Serum:

Pooled normal human serum of healthy donors having

no history of infection with GC (the generous gift from Dr.
William M. Shafer, Department of microbiology and
immunology, School of Medicine, Atlanta, GA. 30322) were
stored in 1ml portions in micro-centrifuge tubes at -70°C
until use.

The serum was thawed at room temperature

immediately before use and used only once.
Isolation of PII variants:

Colonies showing varying opacity

were restreaked and grown for 18-2Oh on clear typing medium.
Colonies from those plates were harvested, solubilized, and
separated by 12.5% of SDS-PAGE gel and stained for
identification of PII expression.

Bacteria from the same

plate were used for the serum killing assays.
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TABLE I:
Strains of Neisseria gonorrhoea used, origins and serum
killing phenotypes
STRAIN
FA899 W.

SOURCE

PERCENT KILLING

SERUM-KILLING

± S.E.M.2
2.4±8.1

shafer1:FA889XFA19

PHENOTYPE3
SR

FA102

"

:FA48XFA19

12.4±6.8

SR

WS1

"

:spontaneous pyocinR 102.4±0.0

SS

mutant of FA102
WS2

"

:FA899XWS1

98.4±0.0

SS

WS3

"

:FA899xWSl

102.4±0.0

SS

WS4

"

:WS2xFA102

42.9±7.5

SR

WS5

"

:WS2xFA102

43.9±6.1

SR

1

- Dr. William M. Shafer, Department of Microbiology and

Immunology, Emory University School of Medicine, Atlanta, GA
30322,and The Veterans Administration Medical Center,
Decatur, GA 30033
2 _ Percent decrease in cfu with 25% pooled normal human
serum (PNHS)± standard error of the mean (S.E.M.)
3

- Serum resistant (SR)- >50% survival in 25% PNHS; Serum

sensitive (SS)- <50% survival in 25% PNHS
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Bactericidal Hicroassay:

The microbactericidal assay, a

method to determine serum bactericidal activity, performed
as described by Schneider and Griffiss 1982 (47, 67, 94),
was used in this experiment to determine the serum
sensitivity of all the PII variants in seven strains of GC.
As mentioned before, the cells tended to adhere together
when they express PII.

We faced the problem of the cells

sticking together to form the colonies on the plates while
performing the dilution plate assay (a common and reliable
method used to determine serum sensitivity of bacteria by
many scientists).

The accuracy of results was largely

affected by this characteristic of Pll-bearing cells.

We

tried several methods in order to solve this problem:

I. To

remove GC aggregates, the suspensions were homogenized by
vortex mixing and then centrifuged at 500g for 10 min before
performing the dilution plate assay which was suggested by
P.R. Lambeden (46).
the cells.

II. The sonicator was used to separate

None of these methods worked very well.

The

first method did not separate the cells any better; the
irregular shaped colonies which formed from more than one
cell still appeared on the plates.

Under the second method,

if the suspensions were sonicated less the 5 min it did not
affect the cell homogenate, but more than 5 minutes would
largely reduce the cell counts, indicating some cells were
killed in the process.

The bactericidal microassay avoids

the requirement for accurate counting of the colonies, so
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TABLE II:
Protein I type, migration of LPS and H.8 antigen of seven
strains of GC used

Strain

P.I type

LPS migration

H.8 migration

FA899

P.IB9

Slow

Intermediate

FA102

P.IA1

Intermediate

Intermediate

WS1

P.IA1

Fast

Fast

WS2

P.IB9

Fast

Fast

WS3

P.IA1

Fast

Fast

WS4

P.IB9

Slow

Slow

WS5

P.IA1

Slow

Slow

24

the results were not affected by the adhering characteristic
of Pll-expressing cells.

In this particular experiment, the

microassay method appears to be more appropriate than the
other serum bactericidal assay.

Also in our lab, Robin

Pettit compared the dilution plate assay with the
microassay.

Although little correlation has been found

between these two assays in her experiments, it has been
shown that the microassay was still a rapid, repeatable and
reliable method to determine serum bactericidal activity.
So we used the serum microassay instead of the dilution
plates assay for serum bactericidal experiments.
Eighteen hour cultures of bacteria were suspended in
the clear typing medium lacking agar (76) and the organisms
were dispersed by vortexing.

The suspensions were adjusted

to 0.30 optical density at 600 (about 3x10® CFU/ml) with
Coleman Junior II Spectrophotometer.

Serum (0.2 ml) was

diluted in serial 2-fold dilutions (1:4 to 1:4096) with
clear typing broth in a sterile, flat-bottomed 24 well
tissue culture micro-titer plate (Corning Glass Works,
Corninig, NY).

The serial two-fold dilutions of 0.2 ml of

serum in clear typing broth were also made in sterile 24
well tissue culture microtiter plates (Corning Glass Works,
Corning, NY).

An equal volume of clear typing broth

containing about 3xl04 cfu/ml was added to each well.

The

plates were incubated at 37°C for 45 min before overlaid
each well with 0.3 ml of molten agar equilibrated to 52°C.
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All the test plates were then incubated at 37°C for about 20
hours.

The bactericidal titers were determined by the last

serum dilution which killed 100% of the bacteria.

The

controls included incubating the bacteria in both clear
typing broth without serum and heat inactive NHS (HINHS).
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CHAPTER III

RESULTS

General Comments:
A single transparent (non-opaque) colony of each strain
lacking any detectable PII was selected and passed.

During

the passages, we observed that the majority of colonies in
the culture had the characteristics of their parental
colonies which were transparent and did not express any kind
of PIIs (0"). However, there were occasional variants
showing different colony opacity in the culture.

Usually

the colonies of those variants displayed from an
intermediate (o+) degree to a marked (o**) degree of opacity.
These desired colonies with different opacity were selected
and cultured.

As previously stated, the colony opacities

were often associated with different PII expression.

A

sample containing a mixture of opacity variants could
contain organisms expressing different PII species.

Also,

organisms were capable of changing their colony opacity
which generally indicated a change in the PII expression
during the passages.

Of course, the results from a

heterogeneous PII population mixture culture would be
difficult to interpret, as they possibly were contributed by
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any PII variants or all of them within the mixed culture.
For these reasons, the colonies of different variants were
examined very carefully

with a dissecting microscope, using

the criteria of J. Swanson (88) to ensure the right colonies
were picked and passed.
Obtaining pure cultures of opacity (PII) variants in
each strain was very important and was considered to be the
first step of our experiments.
PII Variants in Seven Strains of GC:
PII variants from seven transformant strains, FA102
FA899

WS1

WS2

WS3 WS4 WS5, were selected for this study.

The pure cultures of all the opacity variants in each strain
were harvested by scraping plates and solubilized in the
solubilizing solution with 2-mercaptoethanol at 60°C and 100
°C.

SDS-PAGE was performed with all the solubilized samples

to identify the PIIs expressed by each variant.

The PII

variants were maintained by selective passage on clear
typing medium each day.

In addition, more PII variants were

continuously selected over a six month time period.
The molecular masses of Pis and PIIs of each strain
were determined by separating whole cell (WC) lysates in
12.5% or 15% acrylamide gels and comparing the migration to
standard molecular weight markers.

Whole cell lysates of

each strain were then arranged on the 12.5% and 15% SDS gel
based on the increasing apparent molecular mass of the PIIs
when whole cells were solubilized at 37°C.
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Gels were

stained with 0.2% of CBB or silver, as described by Tsai and
Frash (92).
The CBB stained 12.5% gel of the whole cell lysates of
transparent colonies revealed that Pis in strains WS1, WS3,
WS5, and FA102 migrated identically, having a molecular mass
of about 36 Kd.

The Pis in strains WS2, WS4, and FA899 also

showed the identical migrations on the 12.5% CBB stained SDS
gel with an the apparent molecular mass of around 37 Kd
(Fig. 1).
The majority of the population in our stock cultures
were transparent and, therefore,did not express PIIs.
However,

the opaque colonies occasionally arose from the

transparent parents.

Usually one or two distinct opacity

variants were regularly selected among the progeny of
transparent PII" colonies of each strain.

The differences

in colony opacities were due to the different PII expressed
in these colonies, as illustrated in table III.
In the seven experimental strains, the transparent
colony phenotype usually correlated with a PII" variant.
The only exception was in the strain FA899, where no truly
transparent phenotype colonies could be found within the
experimental period of more than a half year.

Therefore, a

PII" variant in FA899 was selected from the colonies which
had intermediate opacity (0+).

In all other strains, the

intermediate (0+) colony opacity was associated with a
single PII that had a molecular mass of about 25.2 Kd.
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But

the variant expressing the 25.2 Kd PII protein in strain
FA899 appeared to have marked (0++) colony opacity.

The

rest of the PIIs selected from seven transformant strains
imparted marked opacity (0++) to the colonies.
Unfortunately, it was not possible to predict the particular
PII types based on the 0** phenotypes.

Therefore, several

0++ colonies were selected, solubilized, and separated on
the SDS-PAGE gel in order to determine the PII types present
in each colonial isolate.

The expression of different PIIs

was verified in those colonies that appeared to have the 0++
phenotype by the SDS-PAGE.
The following results were obtained for each GC strain
used in this study:
Strain WS1:

Fig. 2 show the different PIIs in strain

WS1 in a 12.5% SDS gel stained with CBB.

The LPS type of

each variant was determined by separating the whole cell
lysates in the 15% double crosslinker SDS gel and staining
with Silver.
Fig. 2 A is a CBB stained gel of lysates of strain WS1.
The PI of each variant appears to be identical on the gel.
We

isolated six PII variants in WS1.

One had no PIIs (lane

1); three of them possessed only a single PII protein (lanes
2, 3, 4); and the other two expressed two PII proteins each
(lane 5, 6).

The molecular masses of the PIIs were

estimated by comparison with standard molecular weight
markers.

Among the variants, we noticed PII protein bands
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of four distinct electrophoretic mobilities.
25.2, 25.6, 26 Kd PIIs.
modifiable.

They are 24.8,

All of the PII proteins were heat

At 100°C, the PII bands seen at 60° C (left)

disappeared and the new bands appeared with higher molecular
mass around 30 Kd.

Lane 1: no PII band was seen.

Lane 2:

one PII band with a molecular mass of about 25.2 Kd
appeared.
Kd.

Lane 3: the PII of this variant was about 25.6

Lane 4: the PII of this variant was about 26 Kd.

Lane

5: two PII bands appeared. One was 25.6 Kd, the same as in
lane 3, and the second had molecular mass of about 24.8 Kd.
When heated at 100°C this 24.8 Kd PII band disappeared and a
new band with molecular mass 28 Kd appeared.
two PII bands also.

Lane 6: had

They were 26 and 25.6 Kd (same as lane

4, and lane 3).
In WS1, we found that the transparent colonies did not
express any PIIs.

The intermediated (0+) colony opacity was

associated with 25.2 Kd PII.

The rest of the PII variants

showed the same marked (0++) colony opacity.

No obvious

differences in colony opacity were observed among these
marked (0++) colonies which were verified to express
different PIIs on the SDS-PAGE gel.
Fig. 2 B shows the LPS pattern of PII variants in WS1.
No differences were found in LPS among the PII variants.
WS2:

Like WS1, four distinctive PII protein bands were

detected by 12.5% SDS gel with CBB staining (Fig. 3 A).
60°C, from left to right. Lane 1: no PII.
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At

Lane 2: 24.8 Kd

PII.

Lane 3: 25.2 Kd PII.

Kd PII.

Lane 4: 25.6 Kd PII.

Lane 6: two PIIs 26 Kd and 25.6 Kd.

Lane 5: 26

All PIIs were

heat modifiable in WS2.

The 24.8 Kd PII band at 60°C moved

to 28 Kd area at 100°C.

Other PIIs moved to around 30 Kd.

In WS2, the transparent colonies did not express any
PIIs.

Expression of the 25.2 Kd PII displayed intermediated

colony opacity and the remaining PIIs -24.8, 26- Kd had
marked colony opacity.
No differences in LPS were detected among the PII
variants in WS2 (Fig. 3. B).
WS3:

Five PII variants were selected with different

PIIs expressed.

One had no PIIs.

Three of them expressed a

single PII protein while another one expressed two PIIs at
same time. In sum, three PII proteins (24.8, 25.2 and 26 Kd)
were found in WS3.
Non-PII expressing colonies were transparent while the
expression of a 25.2 Kd PII resulted in intermediated colony
opacity.

Expression of the other two PIIs (24,8 and 26 Kd)

resulted in marked colony opacity.

No difference in opacity

could be distinguished between them, but 12.5% SDS gel with
CBB staining verified that different PIIs were expressed in
these two variants.
No differences in the LPS were found among the PII
variants of WS3 in a 15% double crosslinker SDS gel with
silver stain.
WS4:

Four distinctive PII bands were found
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with

molecular masses around 25.2, 25.6, 26 and 26.7 Kd in strain
WS4 (Fig. 5 A).

As with the other strains, transparent

colonies expressed no PIIs.

The expression of the 25.2 Kd

PII resulted in an intermediate colony opacity.

The other

Pll-expressing colonies had marked colony opacity.
A 15% double crosslinker SDS gel, stained with silver,
revealed unexpected differences in the LPS expressed among
the PII variants.

Lane 1 and lane 4 were non-PII and 26 Kd

PII expressing variants.

Respectively, the LPS of these two

variants migrated more slowly than the LPS of the rest of
the PII variants on the gel.
To further confirm the observed LPS differences in this
strain, the new cell isolates were selected from the stock
culture that expressed the same PIIs. The new samples from
these isolates were analyzed by SDS-PAGE.

The results were

the same, as shown in Fig. 5 B.
WS5:

Fig. 6 A shows that only two PIIs types were

expressed by WS5.

The apparent molecular masses of these

two PII are about 25.2 Kd (Lane 2) and 26 Kd (Lane 3).
The LPS among the two PII variants in WS5 appeared to
be the same on the 15% double crossliker SDS gel stained
with silver (Fig. 6 B).
FA102:

Four types of PII variants were selected from

FA102 (Fig. 7 A).

One did not express any PIIs, the others

expressed either the 24.8 Kd, 25.2 Kd, or 26 Kd PIIs.

As

demonstrated in the other strains, the PIIs in FA102 were
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also heat modifiable.

The 24.8 Kd PII band (at 60°C) moved

to 28 Kd (at 100°C). The other PII bands moved to the area
around 30 Kd (at 100°C).
In FA102, transparent colonies did not express any
PIIs.

The 25.2 Kd Pll-expressing colonies had intermediate

(0+) colony opacity and the 26 Kd PII was associated with
marked (0*+) colony opacity.

No differences in LPS were

detected among the PII variants in FA102 on the 15% double
crosslinker silver stained gel (Fig. 7 B).
FA899:

Six PII variants were found in strain FA899

(Fig. 8 A), but only two colony opacities were found in this
strain: the intermediate (0+) and marked (0++) colony
opacities.

No transparent colonies were ever observed in

our experiments within a time period of more than six
months.

The PII " variant was selected from intermediate

opacity colonies this was unusual, since the non-PII
expressing colonies were transparent in the other six
experimental strains.

The other PII variants all showed

marked colony opacity.
Four distinct PII bands were recognized on the CBB
stained gel.

These PIIs appeared in the variants in

different combinations.

Four variants possessed only one

PII each, 25.2, 25.6, 26 and 26,7 Kd, while the other two
variants expressed two PIIs in each variant at the same
time.

No difference was observed in the LPS among the

variants in FA899 with silver stained 15% double crosslinker
34

SDS gel (Fig. 8 B).
Table III summarizes the Pll-expression of the seven
strains used in this study.
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Figure 1:
Separation of WC lvsates of seven strains of N. gonorrhoea
in 12.5% polvacrvlamide gel
This Coomassie Brilliant blue (CBB) stained 12.5% SDS
gel shows the migration of the Pis in the seven experimental
strains.

The major outer proteins (Pis) from strains, WS1,

WS3, WS5 and FA102 migrated to same position in the gel,
having a molecular mass around 36 Kd.

The Pis from strains

WS2, WS4 and FA899 also migrated to the same position in the
gel, having a molecular mass of about 37 Kd.

Molecular mass

markers (MW) are expressed in thousands of daltons.
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FIGURE 2:
SDS-PAGE profiles of strain WS1 opacity variants
Whole cells of each PII variant were solubilized at
either 60°C and 100°C and separated in 12.5% SDS gels in the
order of increasing apparent molecular mass of PII molecules
at 60°C.
A 12.5% SDS gel of 6 colony isolates (Lanes 1-6) were
solubilized at either 60°C or 100°C and stained with
Coomassie Brilliant blue (CBB) (Fig. 2 A).

The major outer

membrane protein PI and the outer protein lis are identified
as (PI) and (PII) on the gel.
A 15% double crosslinker SDS gel was stained with
silver (SIL) to reveal Lipopolysaccharide (LPS) migration
Fig. 2 B).

Molecular mass markers (MW) are expressed in

thousands of daltons.
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FIGURE 3:
SDS-PAGE profiles of strain WS2 opacity variants

A 12.5% SDS gel stained with Coomassie Brilliant blue
(BBC) shows the different PIIs in each PII variant (Fig. 3
A).

The major outer membrane protein PI and outer membrane

II are identified as (PI) and (PII) on the gel.
Whole cell lysates was separated in 15% double
crosslinker SDS gel and stained with silver (SIL) to show
the lipopolysaccharide (LPS) among the PII variants (Fig. 3
B).

Molecular mass markers (MW) are expressed in thousands

of daltons.
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FIGURE 4:
SDS-PAGE profiles of strain WS3 opacity variants

The whole cell lysates of each PII variant were
solubilized at two different temperatures (at 60°C and 100°)
and then separated on the 12.5% SDS gel (Fig 4 A).
was stained with Coomassie Brilliant blue (CBB).

The gel

The major

outer membrane PI and outer membrane II are identified as
(PI) and (PII) on the gel.
The 15% double crosslinker SDS gel was used to
separated the whole cell lysates in strain WS3 to show
lipopolysaccharide (LPS) (Fig. 4 B).
silver (SIL).

Gel was stained with

Molecular mass markers (MW) are expressed in

thousands of daltons.

42

*

:annou

FIGURE 5:
SDS—PAGE profiles of strain WS4 opacity variants

The whole cell lysate of each PII variant, prepared at
60°C (on the left) and 100°C (on the right), was loaded to
12.5% SDS gel (Fig. 5 A).

We visualized the protein bands

on the gel by staining with Coomassie Brilliant blue (CBB).
The major outer membrane protein PI and outer membrane
protein II are identified as (PI) and (PII) on the gel.
The 15% SDS gel separated the whole cell lysates of the
PII variants in strain WS4 with silver stain (SIL) to show
the lipopolysaccharide (LPS) (Fig. 5 B).

Molecular mass

markers (MW) are expressed in thousands of daltons.
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FIGURE 6:
SDS—PAGE profiles of strain WS5 opacity variants.

The samples of each PII variant in strain WS5 were
separated on the 12.5% SDS gel (Fig. 6 A).

The gel was

stained with 0.2% Coomassie Brilliant blue (CBB). The major
outer membrane protein PI and outer membrane protein are
identified on the gel as (PI) and (PII).
Lipopolysaccharide (LPS) showed on a 15% double
crosslinker SDS gel with silver stain (SIL) (Fig. 6 B).

No

differences are seen among the PII variants in WS5.
Molecular mass markers (MW) are identified in thousands of
daltons.

46

FIGURE: 6
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FIGURE 7:
SDS-PAGE profiles of strain FA102 opacity variants.

Coomassie Brilliant blue (CBB) stained 12.5% SDS gel
show the different PII bands in each variant in the strain
FA102 (Fig. 7 A).

The abbreviations of (PI) and (PII) on

the gel are identified as major outer membrane protein and
outer membrane protein II.
A double crosslinker SDS-PAGE gel with silver stain
(SIL) show the lipopolysaccharide (LPS) in each PII variant
(Fig. 7 B).

Molecular mass markers (MW) are expressed in

thousands of daltons.
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FIGURE 8:
SDS—PAGE profiles of strain FA899 opacity variants.

A Coomassie Brilliant blue (CBB) stained 12.5% SDS gel,
showing the PIIs in the PII variants in strain FA899 (Fig. 8
A).

The abbreviation of major membrane protein and outer

membrane II are identified as (PI) and (PII) in this Figure.

A silver stained (SIL) 15% double crosslinker SDS gel
shows migration of lipopolysaccharide (LPS) in the PII
variants (Fig. 8 B).

Molecular mass markers (MW) are

expressed in thousands of daltons.
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Table III:
The opacity (PII) variants of seven strains of GC

PII variants
Mol. MasPII*
No PII

WS1

WS2

WS3

WS4

+

+

+

+

24•8Kd
+

+

+

+

25.6Kd

+

+

+

+

26Kd

+

+

+
+

26.7Kd

+

+

+

+

+

+

+

+

+

+

+

+

+

+

25.2Kd*
26.7Kd

:

+
+

+
•

All the samples were prepared at 60°C and separated on a

12.5% of SDS gel with CBB stain.

The molecular masses of

PIIs in each variant were estimated by comparison with
standard molecular weight markers.
*:

FA102

+

25.2Kd*
25.6Kd

25.6Kd*
26Kd

FA899

+

+

25.2Kd

24.8Kd*
25.6Kd

WS5

The variants express two PII types.
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The serum sensitivity of PII variants in seven strains of GC
There is no single technique which has emerged as a
standard assay for determination of serum activity.

The

bewildering array of assays made meaningful comparison among
studies very difficult.

Several assays have been generally

applied to determine the serum sensitivity of gram-negative
bacteria.

One

most commonly used method is dilution plate

assay; another is the microbactericidal assay (microassay).
In our study, we chose the microassay method, because of the
advantages for our particular experiments with PIIs as
discussed in the materials and methods section.
The NHS serum killing titers (the last serum dilutions
that kills 100% of bacteria) for the seven strains used in
this study were determined using the microassay in a 2-fold
serum dilution system.

The results of serum sensitivities

for these transformant strains are shown in figure 9.
Strain FA899 was the most serum resistant strain of all with
a bactericidal titer 8 (100% bacteria was killed at 1:8
serum dilution).

The WS5 appeared to be the most serum

sensitive strain with a bactericidal titer 526.
quite serum sensitive with a titer 256.

WS2 was

The rest of the

strains were comparably serum resistant, FA102 and WS4 had
the titer 128.

The WS1, WS3 had the titer 64.

No differences were found in the serum sensitivities
among the PII variants.

As the results stated, the same

titer was observed in all the PII variants as was seen in
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the transparent colony types.

No differences existed, which

seemed unlikely, since previous studies by several groups
(42, 71) had demonstrated the differences in serum killing
that correlated with Pll-expression.
The serum dilutions in the experiments were 2-fold.
The differences in serum dilution between each wells become
much larger as the dilution increased.

Serum dilution of

the first well was 1:4 and was 1:8 in the second well; the
difference in serum dilution between those two wells was
1:4.

The difference between well 7 and 8 was 1:256, while

the difference between wells 10 and 11 was 1:2048.

The

titers of most our experimental strains, determined by
microassay, were quite high.

This meant that the difference

in serum dilution between each well near the titer area was
quite large.

Therefore, modest differences in killing might

not be seen using 2-fold serum dilution.

To solve this

problem, progressively smaller dilutions were made around
the titer for all variants of each strain.
new titer was found each time.

A more accurate

Using the new titers, we

made dilutions around them even further.

As a result, the

differences in the serum sensitivity among the PII variants
became apparent (Table IV).
With the individual serials smaller serum dilutions,
the differences in the serum sensitivities among the PII
variants have been shown (table IV).

These differences in

the serum sensitivity are well correlated with the different
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PIIs in each variants.

The transparent colonies have the

highest serum titer, and the different isogeneic opaque
colonies have lower titers These differences are only
associated with PIIs expressing, not with the Pis and LPS
changes.
The HINHS, used as a control for all the experiments,
was prepared by the standard method.

The complement

activity in the HINHS has been abrogated by heating to 56°C
for 30 minutes.

The results are show on Figure 9.

In general, the bactericidal activities of NHS are
mediated by the complement.
inactivated by heating.

In HINHS, the complement was

The bactericidal activity of this

serum should abrogated with the inactivation of the
complement.

The results from our serum test are quite

unexpected.

The HINHS has almost the same killing as the

NHS (Fig. 9).
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FIGURE 9:
Microtiter bactericidal assay results from seven
gonorrheal strains using 2-fold serum dilutions.

The titers

are the reciprocal of the last dilution killing 100% of the
test strains. The same titer was observed for all the PII
variants in each strain with the 2-fold serum dilutions
system.

The titer for each PII variant appeared to be the

same.
The bars are the mean of duplicated samples.

The

hatched bars indicates the pooled normal human serum and the
solid bars indicate the heat-inactive pooled normal human
serum (HINHS).
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No differences have been found in serum sensitivities
among the PII variants with the 2-fold serum dilution
system.

The smaller serum dilutions have been made around

the titers that observed from 2-fold dilution for each
strain.
Eleven smaller serum dilutions were made in WSl around
its bactericidal titer (64) from 1:36 to 1:116 with 1:8
serum dilution difference between each well.

The new Titers

for each PII variant in WSl from the smaller serum dilution
system are shown in table IV.

From results, we have noticed

that the non-PII expressing transparent colonies tend to
have the highest titer (76), and the rest of variants have
titers from 60 to 68.

One PII variant with 25.2 Kd PII has

the same titer (76) as the transparent colonies.
The bactericidal titer of WS2 using the microassay in
2-fold serum dilutions was 256 (Fig. 8).

Eleven smaller

serum dilutions were made around the titer from 1:128 to
1:562 with 1:35 difference between each dilution.

Another

new titer (268) was found, but still no differences have
shown in serum sensitivity among the PII variants .
Another set of 11 smaller serum dilutions was made
around the new titer (268) from 1:248 to 1:328.

There was

1:8 serum dilution difference between each well.

With this

secondary smaller serum dilution, the differences in the
serum sensitivities among the PII variants finally appeared
(table IV).

We have noticed in WS2 also that the
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transparent colonies tend to have the highest titer (296)
among the PII variants.

It

exhibited that the transparent

colonies were killed at greater serum dilution than that of
other PII variants which means the transparent colonies are
less resistant to the NHS than the rest of the PII variants.
The serum titer for WS3 was 64 in the 2-fold serum
dilution.

Abundant growth was observed in the next well

that had serum dilution 1:128.

This suggested that the most

accurate titers for PII variants could be located between 64
and 128, and closer to 64.
A set of 11 smaller serum dilutions was made from 1:32
to 1:116 with an equal dilution difference of 1:8 between
each well.

The titer for transparent (no PII) and 25.2 Kd

PII variant

was 76, and the other two PII variants was 68.

We tried to determine if more differences could be
found among the PII variants in WS3.

The eleven even

smaller serum dilutions were made from 1:60 to 1:80 with
only 1:2 serum dilution difference between each well.
Differences in killing were observed (table IV).

The titer

for transparent colonies was 68, the other 25.2 Kd PII
variant had the same titer as the transparent (no PII)
colonies.

The rest of PII variants had lower titers than

the transparent colonies.
Eleven smaller serum dilutions were made in WS4.

They

were around titer 128 (Fig. 8) with the dilutions from 1:114
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to 1:194 and 1:8 apart.

Results are shown on the table IV.

The trans-parent colonies have the highest serum titer (194)
among the PII variants.

The other PII variants have lower

serum titers than the no PII expressing colonies.

Further

dilutions were also made, but no more differences have
appeared.

I
j

For WS5, the titer in 2-fold dilution was 256.

At this

point, no difference in the serum sensitivity has been found
among the PII variants. Therefore, eleven smaller dilutions
have been made from 1:206 to 1:306.
variant are shown on table IV.

New titers for each

Like other strains, the

highest serum titer (286) has appeared in the transparent
colonies in WS5.
The strain FA102 had the same bactericidal titer as
strain WS4 (Fig. 8) with 2-fold serum dilution.

The same

secondary 11 smaller serum dilutions were made as in WS4.
The titers are shown on table IV.

The highest serum titer

(154) was also with the transparent colonies.
Strain FA899 was very serum resistant in microasssy.
The titer was 8 with 2-fold serum dilution.

We made 8

secondary serum dilutions from 1:4 to 1:32 and 1:4 apart.
Secondary titers were found and showed on table IV.

The

highest serum titer in this strain was 20. The transparent
phenotype colonies and a 26.7 Kd expressing variant had the
same titer 20, and the rest of PII variants had lower serum
titers.
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Table IV :
The serum sensitivities of PII variants to NHS

PII VARIANTS
WSl
Mol. WtPII

WS2

76

296

No PII
24.8Kd

BACTERICIDAL TITERSA
WS5
WS3
WS4
FA899

68

280

194

76

288

68

122

25.6Kd

68

264

66

186

26Kd

60

264

24.8Kd*
25.6Kd

154

226

266

12

130

8

146

8

130

20

68
288

25.2Kd*
26.7Kd

A

162
66

25.2Kd*
26Kd

25.6Kd*
26Kd

20

178

25.2Kd

26.7Kd

286

FA102

12
64

68

186

: The bactercidal titers of seven strains were not

determined under a standard serum dilution system as Fig. 9.
The serum dilutions were made differently for individual
strains, but the same serum dilutions were used for all the
variants within a single strain.
* : The variants express two PII types
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CHAPTER IV

DISCUSSION

Outer membrane proteins II (PIIs) are dominant variable
surface structures of GC (6, 25).

The functions of this

group of proteins have not been definitively determined, but
they are associated with pathogenesis (29, 66) and believed
to be an important colonization factor (16, 45, 65).

PIIs

correlate with colony-opacity, and are called opacityassociated proteins (25, 31, 88, 90, 96).

The roles PIIs

play in GC infection appear to be quite complex.
In general, bacteria with transparent phenotype do
not express any PIIs.

Expression of different PIIs is

associated with distinctive colony morphologies and
opacities.

Colony opacity is believed to be one of the

reliable criteria in PII selection.

However, the PIIs are

not always associated with colony opacity.

In strain JS1

(88), one PII protein, called Plla, was not correlated with
any colony opacities.

The colonies expressing this PII

appeared to be as transparent as the non-PII expressing
colonies.
In the study of seven transformant strains of GC, we
have

selected the non-PII expressing variants based on the
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transparent phenotype.

Only strain FA899 failed to express

a transparent phenotype colonies despite the absence of any
PIIs.

The non-PII expressing variant in this strain was

selected from the colonies which have an intermediate
opacity, as indicated in the results section.

This suggests

that besides PIIs the other components in the membrane, such
as LPS, may have contributed to the colony opacity in this
strain.

In majority of our experimental strains, the 25.2

Kd PII variant generally impacted an intermediate colony
opacity, but appeared to impact a marked colony opacity in
FA899.
The factor(s) that could possibly affect colony opacity
are most likely the variable structures on the membrane.

It

is unlikely that the PI subclass contributed to the colony
opacity.

The PI proteins of each strain showed no variation

either in migration or concentration, regardless of the PII
variation occurring in each strain.

This was true whether

the strains expressed PIA (WSl, WS3, WS5, and FA102) or PIB
(WS2, WS4, and FA899) (Table II).

Therefore,

the factor(s)

other than Pis must contribute to the colony opacity.
LPS, a variable membrane structure, could possibly play
a role in colony opacity.

To determine if LPS contributed

to opacity variation, a 15% double crosslinker SDS-PAGE gel
was strained with silver to examine LPS in all PII variants.
No difference in LPS was revealed in six strains with the
exception of strain WS4, in which the LPS patterns in two
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PII variants were different (Fig. 5 B), with the LPS in the
non-PII expressing colony (Lane 1) and 26 Kd PII (Lane 3)
being different from others.

The LPS in these two PII

variants moved slower than the LPS in the rest of the
variants in this strain.

However, no correlation could be

found between LPS differences and the difference in colony
opacity.

If LPS had affected the colony opacity, it would

likely have shown up in the non-PII expressing transparent
colonies.

We also has not found any differences in LPS

among the PII variants in FA899 which never did express the
transparent colony opacity phenotype.

No changes have been

observed in colony opacity in these colonies, indicating
that LPS did not influence colony opacity.

Therefore, it

seems that LPS did not influence colony opacity in our
experiments.

Since we did not do extensive studies to

identify LPS variation within our strains, it is still
possible that LPS variation could influence colony opacity.
In WSl, four distinctive PIIs are found. They are 24.8,
25.2, 25.6, 26 Kd.

WSl was a spontaneous pyocinR mutant of

FA102 (Table I). In FA102, except for the transparent nonPII expressing colony, three PIIs, (25.2, 25.6, 26 Kd) were
found.

Comparing the PIIs in these two strains, one

additional (24.8 Kd) PII has appeared in WSl that has not
been found in FA102.

Since FA102 was considered to be the

only parent of WSl,

we assumed that the DNA sequence code

for 24.8 Kd PII probably also existed in the FA102.
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However, we have not successfully selected this PII.
The PII gene could exist in the genome of FA102 in the
form of an unexpressed gene or it might exist as a partial
gene, which could not express itself except by recombining
with homologous sequences in another complete genes (seminar
of J. Swanson).

The reasons that the 24.8 Kd PII was not

found in FA102 could possibly be:

We simply missed this PII

while we selecting the PII variants; special conditions
might be needed for expression of this PII protein; or
promoter of this gene was inactivated, so the gene can no
longer to be expressed.

It is also possible that a

recombination event occurred in the DNA sequence of WSl
along with the mutation in the gene which controls the
pyocin resistance.

If so, the 24.8 Kd PII gene might have

been created during the process.

This raises several

unanswered questions about the stability and expression of
PII genes that are beyond the scope of this study.
WS2 has two parent strains, FA899 and WSl.

Each

parental strain has four PIIs. Three of them were common to
both parents and were also expressed in the daughter strain
WS2 (25.2 Kd, 25.6 Kd and 26 Kd).

The other two were unique

in each parental strain, with WSl expressing a 24.8 Kd PII
and FA899 a 26.7 Kd PII.

The (24.8 Kd) PII in WSl also has

been seen in the daughter strain WS2.

But the 26.7 Kd PII

that was expressed in another parent FA899 has not been
found in WS2.
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PII genes from both parents could be transferred to the
daughter strain.

It is possible that the DNA sequence for

this 26.7 Kd PII was transferred from the parent FA899 to
daughter WS2, but due to present of suppressor, loss of
correct promoter or intervening sequence was not expressed.
Conversely, the sequence may not has been successfully
transferred to the daughter gamone.
several methods;

This could be tested by

We have learned , when bacteria are grown

under different stresses, the cell can change its gene
expression, as the cell under heat shock.

Suppressed genes

could be turned on and the others could be turned off.

We

can put strain WS2 under different stresses to see whether
or not this 26.7 Kd PII can be expressed.

The positive

result would confirm the existence of the gene, but the
negative result does not necessarily mean the absence of
this gene.

Another new technique allows us sequencing of

the PII genes in WS2 or specific probes can be used to
detect the existence of the gene in the gamone.
All the PIIs expressed by WS2 were also expressed in
its parental strains.

No new PIIs were found in the progeny

(WS2) that were not also found in the parental strains
(FA899 or WSl).
WS3 has the same parents (WSl and FA899) as WS2.
WS3, three PIIs have been selected.
and 26.7 Kd.

In

They are 25.2, 25.6,

The 26.7 Kd PII expressed in parent FA899 that

has not found in one daughter strain WS2 was shown up in
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WS3.

Two 26.7 Kd PII expression variants have been found in

WS3, one express only 26.7 Kd PII and another express two
PIIs, 26.7 and 25.2 Kd.

It seems that 26.7 Kd PII was

actively expressed in WS3.
Comparing the PII expression parterns in WS2 and WS3,
the 26.7 and 24.8 Kd PIIs was not expressed in same strain.
Another 26.7 Kd expression strain FA899, 24.8 Kd PII has
also not found.

The 24.8 Kd PII was expressed in WS4, 26.7

Kd PII was also not selected from this strain.

This may

imply a possible relationship between those two genes,
expression of one gene inhibited the expression of another.
WS4 has WS2 and FA102 as the parental strains.

In

addition to the transparent variant (no PII), three (24.8,
25.2, 26 Kd) PIIs have been identified in WS4.

All of them

have also appeared in the parents.
WS5 has the same parents as WS4 as shown in Table I.
Only two PIIs have been selected from this strain.

Fewer

PIIs were found in this strain than in either of its parents
(WS2 and FA102).
Expression of PIIs is controlled by a group of opa
genes, which are spread throughout the gonococcal genome
(77).

These genes can be turned on and off at a very high

frequency depending on the number of CTCTT (RC) sequences in
the leader sequence. The number of RC sequences causes a
frameshift within the gene which can either put the PII gene
in or out of frame with ATG initiation codon, so either a
67

functional PII protein or a truncated PII protein could be
synthesized.

The mechanisms that control the high frequency

changes in the number of CTCTT sequences in PII mRNA are
still poorly understood.

They could possibly result from

the slippage or stuttering of RNA polymerase
are transcribed.

as the genes

The unequal crossing-over among the signal

peptide coding regions of different PII genes that causes
the insertion or deletion of RC repeat units could also be
responsible for the changes in the number of RC sequences.
Using gene sequencing and common PII gene probe
techniques, many more PII genes have been identified in the
genome than the PIIs have expressed (77).

This indicates a

lot more PII genes remain in an inactive state in the
genome.

Different genetic movements have been detected

among PII genes:

Gene duplication and conversion generate

new PII coding sequences and increase the structural
variability in the proteins PII family (93); the genetic
transformation of PII genes from donor to the recipient are
confirmed by using MABs (73). These genetic movements could
occur among genes within the genome, or between different
cells, creating many opportunities for new PII coding
sequences.

However, our experiments did not identify any

new PIIs expressed in the daughter strains that were not
also expressed in parental strains.

It is possible that new

PII genes have been created but remain unexpressed in the
genome.

Those PII genes exist in the genome in an inactive
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state (48) when the bacteria are grown under the certain
conditions.

The cells retain the ability to express those

PIIs when it becomes necessary.

This could be confirmed by

comparing PII expressing patterns of a single strain under
different growth conditions.

However, the mechanisms that

prevent PII genes from being expressed under certain
conditions and allow them to be expressed under others are
still not well characterized.
From PIIs expressing patterns of our experimental
strains, we have noticed that almost all PIIs expressed in
daughter strains were also found in at least one of their
parents.

There were not as many as PIIs expressed in each

daughter strains, as we expected.

It is likely that gene

products from a particular gene could serve as suppressor
preventing expression of another gene.
OM proteins II, the colony opacity associated protein
on the surface of GC, are not the only structure that could
contribute to the colony opacity.

The possible involvement

of LPS has not been confirmed in our experiments.

The

possibility of PII genes existing in an inactive state in
the genome is proposed.

Those PII genes can be expressed at

different environmental conditions which could increase
bacterial survival and help bacteria evade the host immune
response.

In efforts to evaluate whether many more PIIs

could be expressed in each strain, future experiments will
observe the PII expression of strains under different growth
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conditions.
Serum resistance is a common phenomenon of gramnegative bacteria that has been recognized for many years.
Surprisingly
involved.

little is know about the molecular mechanisms

Like many gram-negative bacteria, differences in

serum resistance have been observed among different strains
of GC.

Adding to the difficulties in determining molecular

factors which contribute to serum resistance is the
variability of results, depending on the bactericidal assay,
the definition of serum resistance (indicated as 90% of
survival, 80% of survival or 20% of survival), the serum
concentration and the source of serum.

As mentioned in the

material and method section, we chose the microassay method
instead of dilution plate assay method for the advantages of
this method in our particular experiment.
Many studies have examined the bactericidal actions of
NHS as a function of colony phenotypes (49, 60), OM protein
I (29) and LPS (92), the important structures on the surface
of the cell which have been associated with serum
sensitivity.

Our studies have been focused on another group

of OM proteins (PIIs).
Previous research indicates that the proteins II on the
surface of GC could affect the serum killing and might be
one important factor in determining the serum sensitivity
(29, 46).

The serum sensitivities are determined by the

presence of the bacterial surface structures which are
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capable of interfering with the formation, attachment, and
subsequent activity of the MAC formed by complements cascade
(91).

In our serum test, it seems that the bactericidal

activity in the microassay measures both complement-mediated
killing and a non-complement-mediated killing mechanism.
Differences in serum sensitivity of non-PII bearing
bacteria has been determined in our seven transformant
experimental strains (Fig. 9).

Our data showed that strain

WS5 was a very serum sensitive strain; it is counted as a
serum resistant strain in table I (the results from dilution
plate assay).

WS4 and FA102 are serum resistant strains in

table I, but appeared to be quite sensitive in our test.
Those differences were caused by the different methods used
to test the serum sensitivity.

The serum concentration used

and the time incubate bacteria with serum are quite
different in these two methods.
Different serum titers have been obtained among the PII
variants with the secondary smaller serum dilution.

The

transparent colonies (having no PII) tended to have higher
killing titer than their isogeneic opaque colonies,
indicating that transparent colonies were more sensitive to
the NHS than opaque colonies.

It suggests that expression

of PIIs enhanced the ability of these strains to resist to
killing by NHS.
Previous reports showed PI and LPS were both
significant in determining the serum sensitivity (29, 75).
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In our experimental strains, the Pis appeared to be
invariable among the PII variants (identical migration on
the SDS gel). The LPS shown on a 15% double crosslinker SDS
gel with silver stain revealed no differences in LPS
structure with the exception of strain WS4.

In strain WS4,

different LPS patterns were seen in non-PII expressing
colonies and the variant express 26 Kd PII.

However, these

differences were not associated with differences in serum
sensitivities.

The transparent colonies were still the most

serum sensitive among the PII variants.

Therefore, LPS

variation did not contribute to the differences in serum
sensitivity in this strain.

No conclusions can be made

based on these LPS variations.

As mentioned before, WS2 and

WS3 have the same parents, a large difference in serum
sensitivity has been observed with the same PII expression
variants in those two strains.

This suggests that PI or PI

combining with LPS are important in affecting serum
sensitivity among strains.
Our results demonstrated that variation in PII
expression has contribute to the variation in serum
sensitivity, and that PIIs rather than the LPS or Pi-type
contributed to the variations in serum killing within each
strain.
The results from our microassay serum tests contradict
a

previous report which suggested the opaque colonies were

less resistant to the NHS than the isogeneic transparent
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colonies (29).

However, our data supports another report

which demonstrated that the expression of PII increased
serum resistance (46).

Results from our serum test

indicated that the transparent colonies were more sensitive
to the NHS than the isogeneic opaque colonies.

We have

found no relationship between a specific PII and the
greatest serum resistance within our experimental strains
We have used the heat-inactivated normal human serum
(HINHS) as one of the controls in our experiment.
Therefore, we did not expect to see significant killing with
this serum with no complement activity, as we believed that
the serum killing of gram-negative bacteria is mediated by
the complement (68, 75, 91).

The inactivation of the

complement should abrogate the bactericidal activity of NHS.
The results from our serum tests with microassay
indicated that HINHS was not only bactericidal to all the
experimental strains, but also had almost as much killing as
intact NHS (Fig. 9).

In an effort to understand this

phenomenon, a set of experiments were performed by using
HINHS with human complement added back (data not shown).

We

hoped to determine if the complement played the same role in
microassay as it did in other serum assays, or if other
unknown mechanisms were involved in the killing in the
microassay method.

Surprisingly, no difference in serum

killing has been observed using HINHS with human complement
adding back, suggesting that the bactericidal activities in
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microassay were mediated by mechanisms other than the
activation of complement.

The substance contributed to the

serum killing in HINHS must be heat stable, since the
bactericidal activity existed after heating the serum at
56°C for 30 minutes.
The same phenomena was also discovered by a colleague
in our lab (61).

She discussed two possibilities:

The

killing could be mediated by 1). toxic fatty acids or 2).
specific Abs.

The bactericidal capacity of HINHS (the c'-

depleted serum) was not affected by doubling the amount of
soluble starch in the medium which could bind to and
neutralize toxic fatty acids, nor decreased by pre-absorbing
the serum with the test strain of GC to get rid of specific
Abs.
Besides the complement, toxic fatty acids and specific
Abs, several other substances in the serum could possibly
contribute the serum killing.

A group of low-molecular-

weight cationic proteins in the serum

termed /?-lysins

possess lethal activity against gram-positive bacteria (91)
and some gram-negative bacteria at very high concentration.
/J-lysins appear to be heat stable (52), and are released
from platelets during the process of blood coagulation.

It

is believed that the primary site of action for /3-lysins is
the cytoplasmic membrane.

No direct lethal action has been

observed against gram-negative bacteria
possessing an integral envelope structure.
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However, GC is

well know to have a "leaky " outer membrane structure; the
outer membrane of GC was more permeable than the other
members in the Enterobacteriaceae family (penicillin can
penetrate OM and kill GC but not effect most gram-negative
bacteria) (52).

Perhaps, this explained our observation.

The data from our experiments provide direct evidence
of the relationships among the PII variants and their
isogeneic transparent colonies in the serum
susceptibilities.

Expressing of PIIs in the GC outer

membrane could not only increase the attachment of bacteria
to different host cells which help establish infection but
also increase serum resistance which enhance bacterial
survival in the internal environments.

PIIs are important

not only in GC infection but also in bacterial survival.
Thus, serum killing in microassay appears unusual;
potentially a group of heat stable low-molecular-weight
cationic proteins in the serum may be involved.
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SUMMARY
Outer membrane protein II (PII) of Neisseria
gonorrhoeae is recognized by their ability to affect colony
opacity.

Our studies on expression of PII in seven strains

indicate that PII is important in affecting colony opacity,
but not the only factor.

A variable surface structure,

lipopolysaccharide (LPS) may play a role in colony opacity;
however, result suggests that effects of LPS on colony
opacity are minimal.
The serum sensitivities of different PII variants in
each strain were examined.

Despite the evidence that

gonococcal resistance to normal human serum is
multifactorial, the use of isogeneic variants shown OMP II
is associated with considerable serum resistance.
The serum bactericidal microassay tests the different
killing aspects of the normal human serum (NHS), it was
revealed by using the complements abrogated serum (heatinactivated normal human serum).

This suggests that serum

killing in the microassay method likely mediated by a group
of heat stable low-molecular-weight cationic proteins termed
0-lysins.

These serum proteins released from platelets

during process of blood coagulation.
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